Therapeutic effect of combination of alagebrium (ALT-711) and sildenafil on erectile function in diabetic rats

International Journal of Impotence Research

Volumn 24, Issue 3, 2012, Pages 114-121

  Gurbuz, N ^a   Sagdic, G ^a   Sanli, A ^a   Ciftcioglu, A ^a   Bassorgun, I ^a   Baykal, A ^a   Usta, M F ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

advanced glycation end products; diabetes mellitus; erectile dysfunction

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALAGEBRIUM; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; SILDENAFIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPORA CAVERNOSA; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERECTILE DYSFUNCTION; IMMUNOHISTOCHEMISTRY; MALE; NERVE STIMULATION; NICK END LABELING; NONHUMAN; PENIS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; DIABETES MELLITUS, EXPERIMENTAL; ERECTILE DYSFUNCTION; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PENILE ERECTION; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RATS; RATS, WISTAR; SULFONES; THIAZOLES;

EID: 84861235669     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.54     Document Type: Article

References (28)

1. Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJG. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl 2003; 24(Suppl): S17-S37. (Pubitemid 37370524)
2. Moore CR, Wang R. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 2006; 8: 675-684. (Pubitemid 44869615)
3. Bivalacqua TJ, Usta MF, Kendirci M, Pradhan L, Alvarez X, Champion HC et al. Superoxide anion production in the rat penis impairs erectile function in diabetes: influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med 2009; 2: 187-198.
4. Usta MF, Bivalacqua TJ, Yang DY, Ramanitharan A, Sell DR, Visvanathan A et al. protective effect of aminoguanidine on erectile function in streptozotocin diabetic rats. J Urol 2003; 170: 1437-1442. (Pubitemid 37108178)
5. Usta MF, Bivalacqua TJ, Koksal IT, Toptas B, Surmen S, Hellstrom WJG. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment. BJU Int 2004; 94: 429-432. (Pubitemid 39120193)
6. Usta MF, Kendirci M, Gür S, Foxwell NA, Bivalacqua TJ, Cellek S et al. The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment. J Sex Med 2006; 3: 242-252.
7. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999; 281: 421-426. (Pubitemid 29069439)
8. De Young L, Yu D, Freeman D, Brock GB. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model. Int J Imp Res 2003; 15: 347-354. (Pubitemid 37376940)
9. Kasai K, Nakamura T, Kase N, Hiraoka T, Suziki R, Koqure F et al. Increased glycosylation of proteins from cataractous lenses in diabetes. Diabetologia 1983; 25: 36-38. (Pubitemid 13070126)
10. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. ClinChem 1993; 39: 2522-2526. (Pubitemid 24008241)
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J BiolChem 1951; 193: 265-275.
12. Bivalacqua TJ, Usta MF, Champion HC, Leungwattanakij S, Dabisch PA, McNamara DB et al. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Imp Res 2004; 16: 21-29. (Pubitemid 38401555)
13. Akingba AG, Burnett AL. Endothelial nitric oxide synthase protein expression, localization, and activity in the penis of the alloxan-induced diabetic rat. Mol Urol 2001; 5: 189-197. (Pubitemid 34038841)
14. Usta MF, Tuncer M, Baykal A, Ciftcioglu MA, Erdogru T, Koksal IT et al. Impact of chronic renal failure and peritoneal dialysis fluids on advanced glycation end product and iNOS levels in penile tissue: an experimental study. Urology 2002; 59: 953-957. (Pubitemid 34522199)
15. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Eng J Med 1998; 338: 1397-1404. (Pubitemid 28221980)
16. Ahn GJ, Yu JY, Choi SM, Kang KK, Ahn BO, Kwon JW et al. Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes. Int J Androl 2005; 28: 260-266. (Pubitemid 41306365)
17. Park K, Ryu KS, Li WJ, Kim SW, Paick JS. Chronic treatment with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of diabetic erectile dysfunction. Eur Urol 2008; 53: 1282-1289.
18. De Young LX, Domes T, Lim K, Carson J, Brock GB. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. Eur Urol 2008; 54: 213-220.
19. Seftel AD, Vaziri ND, Ni Z, Razmjouei K, Fogarty J, Hampel N et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS and eNOS. Urology 1997; 50: 1016-1026. (Pubitemid 28021130)
20. Bierhaus A, Ziegler R, Nawroth PP. Molecular mechanisms of diabetic angiopathy-clues for innovative therapeutic interventions. Horm Res 1998; 50(Suppl 1): 1-5.
21. Liu J, Zhao S, Tang J, Li Z, Zhong T, Liu Y et al. Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen-activated protein kinases and nuclear factor-kappaB. FEBS J 2009; 276: 4598-4606.
22. Nangle MR, Cotter MA, Cameron NE. Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition. Int J Imp Res 2006; 18: 258-263.
23. Angulo J, Peiró C, Cuevas P, Gabancho S, Fernández A, González-Corrochano R et al. The novel antioxidant, AC3056 (2,6-di-t-butyl-4-((dimethyl-4-methoxyphe-nylsilyl)methyloxy)phenol), reverses erectile dysfunction in diabetic rats and improves NO-mediated responses in penile tissue from diabetic men. J Sex Med 2009; 6: 373-387.
24. Alici B, Gumustas H, Ozkara H, Akkus E, Demirel G, Yencilek F et al. Apoptosis in the erectile tissues of diabetic and healthy rats. BJU Int 2000; 85: 326-329. (Pubitemid 30088529)
25. Yamanaka M, Shirai M, Shiiina H, Tanaka Y, Tsujimura A, Matsumia K et al. Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol 2003; 170: 291-297. (Pubitemid 36734481)
26. Gonzales-Cadavid NF, Rajfer J. The pleiotropic effects of inducible nitric oxide synthase (iNOS) on the physiology and pathology of penile erection. Curr Pharm Des 2005; 11: 4041-4046. (Pubitemid 41672475)
27. Cellek S, Rodrigo J, Lobos E, Fernandez P, Serrano J, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003; 52: 2353-2362. (Pubitemid 37059507)
28. Cellek S, Qu W, Schmidt AM, Moncada S. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes. Diabetologia 2004; 47: 331-339. (Pubitemid 38315371)